Cell Therapeutics (CTIC) is seeing shares trade with greater than usual volume today after it announced [...]
Cell Therapeutics Shares Decline On Offering News
MarketNewsVideo.com, Forbes
Fri, 12/09/2011 - 9:30am
BING NEWS:
- Kazia Therapeutics Shares Fall After FDA Declines Accelerated Drug Approval
Kazia Therapeutics stock retreated Tuesday after the FDA said it could consider standard, but not accelerated, approval for the company's brain cancer drug. Shares of the oncology-focused drug company ...
12/31/2024 - 2:11 am | View Link - KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Investor Class Action Lawsuit
CASE ALLEGATIONS : Kyverna is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. In the IPO, Kyverna offered 14.5 million ...
12/29/2024 - 9:33 pm | View Link - Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
The gross proceeds from the offering to Candel are approximately $92 million, before deducting underwriting discounts and commissions and other offering expenses. Candel intends to use the net ...
12/16/2024 - 9:01 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more